Pre-Launch

Smarter launch strategies start with smarter data.

Use real-world evidence to shape your launch strategy—before your first protocol is even finalized. Novellia helps you define populations, uncover care gaps, and build IRB-ready datasets that accelerate development and de-risk launch.

Get Started
Why Pre-Launch RWE Matters

Designing a successful launch starts well before your first study enrolls. But most teams rely on →

Aggregated claims data that lacks granularity
One-off feasibility pulls with limited EMR coverage
Clinical assumptions that miss real-world complexity
Aggregated claims data that lacks granularity
Novellia changes that. We deliver comprehensive, fully linked data to help you validate your strategy, avoid common pitfalls, and approach regulators and payers with confidence from day one.
case study

Read Case Study

Key Capabilities for HEOR, ClinOps & Access

Define real-world patient populations early
Go beyond claims to identify inclusion-ready cohorts, treatment journeys, and comorbidity patterns across 15+ years of linked EMRs.
Uncover care gaps and benchmark label fit
Surface treatment failures, unmet needs, and practice–label misalignment to shape evidence strategy, value messaging, and launch priorities.
Accelerate access, payer, and field readiness
Generate IRB-ready datasets in weeks—fueling HEOR, pricing, medical affairs, and field enablement long before enrollment begins.

What You Can Do With Novellia Pre-Launch

Evidence Planning & Study Design
  • Support pre-IND and protocol optimization by aligning endpoints and eligibility with real-world symptoms
  • De-risk feasibility by testing criteria against 15+ years of EMR data
  • Layer retrospective EMRs and ePROs onto trial patients for richer context
HEOR Model Readiness & Value Strategy
  • Support more efficient label strategy development and generate early inputs for cost-effectiveness and budget impact models
  • Support more efficient label strategy development and generate early inputs for cost-effectiveness and budget impact models
  • Quantify adherence, drop-offs, and disease burden across populations
Access, Market Shaping & Regulatory Strategy
  • Identify subgroups with unmet need for value messaging and segmentation
  • Build synthetic or external comparators using real-world data
  • Equip field and access teams with IRB-ready insights for early engagement

See the whole story, find the pattern, drive better decisions

Our patient-powered database gives you a head start on real-world evidence. Fully structured, authorized, and ready for action.

Get Started

Frequently Asked Questions

Get answers to the most common questions about our platform, data, and results.
What makes Novellia different from traditional RWD vendors?

Unlike fragmented, ‘snapshot-in-time’ datasets, Novellia delivers patient-level, longitudinal records that are automatically cleaned and structured using AI to surface patterns, signals, and insights that traditional RWD simply can’t identify. We deliver precision insights, not just raw cohorts.

Where does your data come from?

Our dataset is sourced directly from patients who use Novellia to unify their health records from across providers, EMRs, and care sites nationwide. Every record is permissioned and structured to support longitudinal analysis.

Who typically uses Novellia inside a biopharma company?

Our primary users include teams in Medical Affairs, RWE/HEOR, Commercial Strategy, Market Access and R&D.

View All FAQs